Intangible assets are growing exponentially as a component of company value, but these assets are often unmanaged due to generally accepted accounting principles (GAAP), which provide no accountability. This research paper reaffirms and expands a proven alternative approach, which utilizes the CoreBrand Index® to measure, value, and manage intangible assets, and their financial impact on …
The researcher provides information about Economic Development Zones to assist readers’ understanding of these programs. Then, business leaders would be able to make informed decisions about the merits of these programs and whether it makes sense for them to relocate their businesses to one of Florida’s Economic Development Zones.
As the Unmanned Aircraft Industry evolves, regulatory actions from Congress will significantly shape the ability to expand and integrate into the existing National Airspace System. The recently finalized 2018 FAA Reauthorization Act has the potential to be the most impactful of legislative actions to date.
Unmanned Aerial Vehicles (UASs), best known as Drones, are expanding in their use, finding new commercial applications and honing their abilities in existing applications. The interviews analyzed here are designed to understand why UAS use has not reached its full commercial potential in the United States.
Unmanned Aerial Vehicles (UASs), best known as Drones, are of ever-increasing popularity, and have given birth to an entirely new industry that encompasses the design, manufacturing, distribution, training, operation, and reporting on developments related to UASs. In addition, UASs augment many pre-existing industries, providing more efficient and effective solutions to a range of industry challenges.
Does the journey of being recruited and participating in a Division I college football program enrich the experience of the student-athlete’s college life athletically and academically?
Can legal insider trading disclosure data reported to the SEC provide an effective tool for identifying investments at the company level?
It is evident that regulations are a double-edged sword. In some instances, regulations promote inefficiencies, rent-seeking and wealth redistribution while in others, they stimulate competition, fair play and innovation.
What management levers can pharmaceutical executives use to frame their thinking around sustaining drug innovations in their companies?